Ann Arbor, Michigan -- Biotechnology company 3D Biomatrix has received $740,000 in venture capital equity investment, according to an SEC regulatory filing.
3D Biomatrix sells three-dimensional cell culture plates and cell matrices for life science research and drug discovery/testing applications.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds. |